Clinical sources and antimicrobial susceptibility of Prevotella timonensis at the university hospital of Montpellier, France

Anaerobe. 2018 Apr:50:19-21. doi: 10.1016/j.anaerobe.2018.01.002. Epub 2018 Jan 4.

Abstract

We describe 84 clinical isolates of Prevotella timonensis recovered between January 2007 and November 2016 at the University Hospital of Montpellier. They were recovered from a variety of clinical samples, mostly of genital and wound origins. All isolates were isolated from a mixed aerobic and anaerobic microbiota. Antimicrobial susceptibility testing of 50 isolates showed 56% of beta-lactamase production and 40% of resistance to clindamycin. One strain was resistant to metronidazole.

Keywords: Anaerobic bacteria; Antimicrobial resistance; Clinical relevance; France; Prevotella timonensis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / pharmacology*
  • Bacteria, Anaerobic / classification
  • Bacteria, Anaerobic / drug effects
  • Bacteria, Anaerobic / isolation & purification
  • Bacteroidaceae Infections / diagnosis*
  • Bacteroidaceae Infections / microbiology*
  • Child
  • Child, Preschool
  • Cross Infection*
  • Drug Resistance, Bacterial / drug effects
  • Female
  • France
  • Hospitals, University*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Metronidazole / pharmacology
  • Microbial Sensitivity Tests*
  • Middle Aged
  • Prevotella / classification
  • Prevotella / drug effects*
  • Prevotella / genetics
  • Prevotella / isolation & purification
  • RNA, Ribosomal, 16S / genetics
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 16S
  • Metronidazole